FDA tells ADHD makers to warn patients of risks
Wed, 21 Feb 2007 04:09 PM EST
... WASHINGTON (Reuters) - All manufacturers of attention deficit drugs should alert patients to possible cardiovascular and psychiatric risks from the medicines, U.S. health officials said on Wednesday. ...
Related Topics
- ADHD
- Maker's Diet
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Smoking Cessation and Continued Risk in Cancer Patients
- Amniocentesis
- Tacrolimus ointment
- Mammography
- Guanfacine
- Carcinogens
- Attention Deficit Hyperactivity (ADHD), Adult
- Attention Deficit Hyperactivity Disorder (ADHD)
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Thalidomide
- Support Groups
- Amantadine
- Food Labeling
- Dopamine
- Medications

Not Signed In -


